Techniques in Regional Anesthesia & Pain Management
Volume 14, Issue 2 , Pages 65-74 , April 2010

Rapid acting analgesics

References 

  1. Carr DB, Goudas LC, Lawrence D, et al. Management of cancer symptoms: pain, depression, and fatigue. In: Evid Rep/Technol Assess. 61:Rockville, MD: Agency for Health Research and Quality, Public Health Service, US Department of Health and Human Services; 2002;Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/cansymp/cansymp.pdf
  2. Mercadante S, Radbruch L, Caraceru A, et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer. 2002;94:832–839
  3. Mercadante S, Arcuri E. Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev. 1998;24:425–432
  4. Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence and characteristics. Pain. 1990;41:273–281
  5. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81:129–134
  6. Kress HG, Orońska A, Kaczmarek Z, et al. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Clin Ther. 2009;31:1177–1191
  7. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage. 2000;20:87–92Erratum in J Pain Symptom Manage 2001 21:265
  8. Costantino HR, Lisbeth Illum B, Gordon Brandt A, et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007;337:1–24
  9. Stanley TH, Ashburn MA. Novel delivery systems: oral transmucosal and intranasal transmucosal. J Pain Symptom Manage. 1992;7:163–171
  10. Dale O, Hjortkjaer T, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand. 2002;46:759–770
  11. Mercadante S, Radbruch L, Davies A, et al. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial. Curr Med Res Opin. 2009;25:2805–2815
  12. Ying W. The nose may help the brain: Intranasal drug delivery for treating neurological diseases. Futures Neurol. 2008;3:1–4
  13. In:  Montvale NJ editors. Physicians' Desk Reference. (ed 58). Thomson, PDR; 2004;p. 211–212
  14. Wolfe T, Bernstone T. Intranasal drug delivery: an alternative to intravenous administration in selected emergency cases. J Emerg Nurs. 2004;30:141–147
  15. Talegaonkar S, Mishra PR. Intranasal delivery: an approach to bypass the blood brain barrier. Indian J Pharmacol. 2004;36:140–147
  16. Olanoff LS, Titus CR, Shea MS, et al. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin. J Clin Invest. 1987;80:890–895
  17. Nave R, Sides EH, Colberg T, et al. Seven hundred and nineteen pharmacokinetics of intranasal fentanyl spray (infS) in subjects with seasonal allergic rhinitis with and without prior administration of oxymetazoline. Eur J Pain. 2009;13:S55–S285
  18. Liu XJ, Gingrich JR, Vargas-Caballero M, et al. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Med N. 2008;14:1325–1332
  19. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–1768
  20. Woolf CJ, Chong MS. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993;77:362–379
  21. Menigaux C, Fletcher D, Dupont X, et al. The benefits of intraoperative small-dose ketamine on postoperative pain after anterior cruciate ligament repair. Anesth Analg. 2000;90:129–135
  22. Himmelseher S, Pfenninger E, Georgieff M. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg. 1996;83:505–512
  23. Hirota K, Hirobumi O, Appadu BL, et al. Stereoselective interaction of ketamine with recombinant [micro sign], [small kappa, Greek], and [small delta, Greek] opioid receptors expressed in Chinese Hamster ovary cells. Anesthesiology. 1999;90:174–182
  24. Sarton E, Teppema LJ, Olievier C, et al. The involvement of the opioid receptor in ketamine-induced respiratory depression and antinociception. Anesth Analg. 2001;93:1495–1500
  25. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998;87:1186–1193
  26. Kennedy RM, Luhmann JD. The “ouchless emergency department.” getting closer: advances in decreasing distress during painful procedures in the emergency department. Pediatr Clin North Am. 1999;6:1215–1247
  27. Borland M, Esson A, Babl F. Procedural sedation in children in the emergency department: A PREDICT study. Emerg Med Australas. 2009;21:71–79
  28. De Pinto M, Jelacic J, Edwards WT. Very-low-dose ketamine for the management of pain and sedation in the ICU. J Opioid Manag. 2008;4:54–56
  29. Richardson P, Mustard L. The management of pain in the burns unit. Burns. 2009;35:921–936
  30. Owens VF, Palmieri TL, Comroe CM, et al. Ketamine: a safe and effective agent for painful procedures in the pediatric burn patient. J Burns CARE Resour. 2006;27:211–216
  31. Paal P, Herff H, Mitterlechner T, et al. Anaesthesia in prehospital emergencies and in the emergency room. Resuscitation. 2010;81:148–154
  32. Bredmose PP, Grier G, Davies GE, Lockey DJ. Pre-hospital use of ketamine in paediatric trauma. Acta Anaesthesiol Scand. 2009;53:543–545
  33. Barash PG, Cullen BF, Stoetling RK. Nonopioid intravenous anesthesia, in Clinical Anesthesia Chapter 13. Philadelphia: Lippincott Williams & Wilkins; 2006;
  34. Domino EF, Chodoff P, Corssen G. Pharmacologic effects of ci-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 1965;6:279–291
  35. Mercadante S, Arcuri E, Tirelli W, et al. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage. 2000;20:246–252
  36. Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain. 1999;82:111–125
  37. Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2003;1:CD003351
  38. Carr DB, Goudas LC, Denman WT, et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain. 2004;108:17–27
  39. Yanagihara Y, Ohtani M, Kariya S, et al. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos. 2003;24:37–43
  40. Huge V, Lauchart M, Magerl W. Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain. Eur J Pain. 2009;[Epub ahead of print]
  41. Mercadante S, Lodi F, Sapio M, et al. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage. 1995;10:564–568
  42. Haines DR, Gaines SP. N of 1 randomized controlled trials of oral ketamine in patients with chronic pain. Pain. 1999;83:283–287
  43. Eide PK, Jørum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347–354
  44. Klepstad P, Borchgrevink PC. Four years treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia. Acta Anaesthsiol Scand. 1997;41:422
  45. Dertwinkel R, Heinrichsa C, Sennea I, et al. Prevention of severe phantom limb pain by perioperative administration of ketamine-an observational study. Acute Pain. 2002;4:9–13
  46. Chia YY, Liu K, Liu YC, et al. Adding ketamine in a multimodal patient-controlled epidural regimen reduces postoperative pain and analgesic consumption. Anesth Analg. 1998;86:1245–1249
  47. Zakine J, Samarcq D, Lorne E, et al. Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: a prospective, randomized, double-blind, controlled study. Anesth Analg. 2008;106:1856–1861
  48. Fu ES, Miguel R, Scharf JE. Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery. Anesth Analg. 1997;84:1086–1090
  49. Tverskoy M, Oz Y, Isakson A, et al. Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesth Analg. 1994;78:205–209
  50. Royblat L, Korotkoruchko A, Katz J, et al. Postoperative pain: the effect of low-dose ketamine in addition to general anesthesia. Anesth Analg. 1993;77:1161–1165
  51. Kollender Y, Bickels J, Stocki D, et al. Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic–oncological patients. Eur J Cancer. 2008;44:954–962
  52. Bell RF, Bahl JB, Moore RA, et al. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev. 2006;1:CD004603
  53. Suzuki M, Tsueda K, Lansing PS, et al. Small-dose ketamine enhances morphine-induced analgesia after outpatient surgery. Anesth Analg. 1999;89:98–103
  54. Malinovsky JM, Servin F, Cozian A, et al. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth. 1996;77:203–207
  55. Walker G, Wilcock A, Manderson C, et al. The acceptability of different routes of administration of analgesia for break through pain. Palliat Med. 2003;17:219–221
  56. White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg. 2002;94:577–585
  57. Kraemer FW, Rose JB. Pharmacologic management of acute pediatric pain. Anesthesiol Clin. 2009;27:241–268
  58. Urban MK, Ya Deau JT, Wukovits B, et al. Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. HSS J. 2008;4:62–65
  59. Carr DB. Intranasal ketamine for acute pain. Acute Pain. 2008;10:193–194
  60. Christensen K, Rogers E, Green GA, et al. Safety and efficacy of intranasal ketamine for acute postoperative pain. Acute Pain. 2007;9:183–192
  61. Klepstad P, Kaasa S, Cherny N, et al. Pain and pain treatments in European palliative care units (a cross sectional survey from the European Association for Palliative Care Research Network). Palliat Med. 2005;19:477–484
  62. Illum L, Watts P, Fisher AN. Intranasal delivery of morphine. J Pharmacol Exp Ther. 2002;301:391–400
  63. Koch M. Via the nose (Innovations in pharmaceutical technology). Drug Deliv. 2002;June:90–94(Available at http://www.iptonline.com/articles/public/IPTTEN90NoPrint.pdf)
  64. Stoker D, Reber K, Carr D, et al. 808 Rylomine (intranasal morphine), a noninvasive alternative to injectable morphine: characterization of analgesic properties and side effects in moderate-to-severe postsurgical pain. Pain J. 2006;7:S53S53
  65. Collins SL, Faura CC, Moore RA, et al. Peak plasma concentrations after oral morphine: a systematic review. J Pain Symptom Manage. 1998;16:388–402
  66. Barash PG, Cullen BF, Stoetling RK. Opioids, in Clinical Anesthesia Chapter 14. Philadelphia: Lippincott Williams & Wilkins; 2006;
  67. Portenoy RK, Taylor D, Messina J, Tremmel L. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opiord-treated patients with cancer. Clin Pain. 2006;22:805–811
  68. Zeppetella G. Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study. Palliat Med. 2001;15:323–328
  69. Coluzzi PH, Schwartzberg L, Conroy JD, et al. Break-through cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate Immediate release (MSIR). Pain. 2001;91:123–130
  70. Chaushu G, Bercovici M, Dori S, et al. Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer. 2000;88:984–987
  71. Christrup LL, Foster D, Popper LD, et al. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, cross over study. Clin Ther. 2008;30:469–481
  72. Paech MJ, Lim CB, Banks SL, et al. A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study. J Anesth. 2003;58:740–744
  73. Zeppetella G. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: A pilot study. J Pain Symptom Manage. 2000;20:253–258
  74. Derry P, Moore S, Andrew R, McQuay J. Single dose oral diclofenac for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;2:CD004768
  75. Williams BS, Buvanendran A. Nonopioid adjuvants in multimodal therapy for acute perioperative pain. Adv Anesth. 2009;27:111–142
  76. Hynes D, McCarroll M, Hiesse-Provost O. Analgesic efficacy of parenteral paracetamol (propacetamol) and diclofenac in post-operative orthopaedic pain. Acta Anaesthesiol Scand. 2006;50:374–381
  77. Morton NS, O'Brien K. Analgesic efficacy of paracetamol and diclofenac in children receiving PCA morphine. Br J Anaesth. 1999;82:715–717
  78. Ready LB, Brown CR, Stahlgren LH, et al. Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain (a double-blind, placebo-controlled, multicenter study). Anesthesiology. 1994;80:1277–1286
  79. Gillberg LE, Harsten AS, Stahl LB. Preoperative diclofenac sodium reduces post-laparoscopy pain. Can J Anesth. 1993;40:406–408
  80. Mercadante S, Sapio M, Caligara M, et al. Opioid-sparing effect of diclofenac in cancer pain. J Pain Symptom Manage. 1997;14:15–20
  81. Mercadante S, Maddaloni S, Roccella S, et al. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 1992;50:151–155
  82. Leeson RM, Harrison S, Ernst CC, et al. Dyloject, a novel injectable diclofenac formulation, offers greater safety and efficacy than Voltarol for postoperative dental pain. Reg Anesth Pain Med. 2007;32:303–310
  83. Gan TJ, Bauer K, Gerson W, et al. A novel parenteral NSAID in acute pain management. Acute Pain. 2008;10:165–166
  84. Rusy LM, Houck CS, Sullivan LJ, et al. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: analgesia and bleeding. Anesth Analogue. 1995;80:226–229
  85. Judkins JH, Dray TG, Hubbell RN. Intraoperative ketorolac and posttonsillectomy bleeding. Arch Otolaryngol Head Neck Surg. 1996;122:937–940
  86. Steinberg RB, Tessier EG. Gastrointestinal bleeding after administration of ketorolac. Anesthesiology. 1993;79:1146
  87. Fragen RJ, Stulberg SD, Wixson R, et al. Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. J Bone Joint Surg. 1995;77:998–1002
  88. Christensen K, Daniels S, Bandy D, et al. Six hundred and forty-three Dyloject, a novel injectable diclofenac: EFFICACY of unexpectedly low doses and faster onset than ketotolac. Eur J Pain. 2006;10:S168
  89. McNicol E, Strassels SA, Goudas L, et al. NSAIDs or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev. 2005;1:CD005180
  90. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–1056
  91. Derry C, Derry S, Moore R, et al. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;3:CD001548
  92. Rosenblum M, Weller RS, Conard PL, et al. Ibuprofen provides longer lasting analgesia than fentanyl after laparoscopic surgery. Anesth Analg. 1991;73:255–259
  93. Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal anti-inflammatory drugs on patient-controlled analgesia morphine side effects: Meta-analysis of randomized controlled trials. Anesthesiology. 2005;102:1249–1260
  94. Southworth S, Peters J, Rock A, et al. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009;31:1922–1935
  95. Toms L, McQuay HJ, Derry S, et al. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev. 2008;4:CD004602
  96. Cobby TF, Crighton IM, Kyriakides K, et al. Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br J Anaesth. 1999;83:253–256
  97. Hyllested M, Jones S, Pedersen JL, et al. Comparative effect of paracetamol, NSAIDs or their combination in ostoperative pain management: A qualitative review. Br J Anaesth. 2002;88:199–214
  98. Beaulieu P. Non-opioid strategies for acute pain management. Can J Anesth. 2007;54:481–485
  99. Alhashemi JA, Alotaibi QA, Mashaat MS, et al. Intravenous acetaminophen vs oral ibuprofen in combination with morphine PCIA after Cesarian delivery. Can J Anesth. 2006;53:1200–1206
  100. Benhamou D, Bouaziz H, Zerrouk N, et al. Audit of ketoprofen prescribing after orthopedic and general surgery. Can J Anesth. 1999;46:109–113
  101. Schug SA, Sidebotham DA, McGuinnety M, et al. Acetaminophen as an adjunct to morphine by patient-controlled analgesia in the management of acute postoperative pain. Anesth Analg. 1998;87:368–372
  102. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: Meta-analysis of randomized controlled trials. Br J Anaesth. 2005;94:505–513
  103. Montgomery JE, Sutherland CJ, Kestin IG, et al. Morphine consumption in patients receiving rectal paracetamol and diclofenac alone and in combination. Br J Anaesth. 1996;77:445–447
  104. Korpela R, Korvenoja P, Meretoja OA. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology. 1999;91:442–447
  105. Fayaz MK, Abel RJ, Pugh SC, et al. Opioid-sparing effects of diclofenac and paracetamol lead to improved outcomes after cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:742–747
  106. Kapota E, Hatziperi A, Lykoudi I, Kouta A. Seven hundred and sixteen paracetamol as an adjunct to patient control analgesia with liver resection: a randomized control trial. Eur J Pain. 2009;13:S55–S285
  107. Atef A, Fawaz AA. Intravenous paracetamol is highly effective in pain treatment after tonsillectomy in adults. Eur Arch Otorhinolaryngol. 2008;265:351–355
  108. Pettersson PH, Jakobsson J, Owall A. Intravenous acetaminophen reduced the use of opioids compared with oral administration after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2005;19:306–309
  109. Leinisch E, Evers S, Kaempfe N, et al. Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study. Pain. 2005;117:396–400
  110. Jarde O, Boccard E. Parenteral versus oral route increases paracetamol efficacy. Clin Drug Invest. 1997;14:474–481
  111. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102:822–831
  112. Moller PL, Juhl GI, Payen-Champenois C, et al. Intravenous acetaminophen (paracetamol): comparable analgesic efficacy, but better local safety than its prodrug, propacetamol, for postoperative pain after third molar surgery. Anesth Analg. 2005;101:90–96

PII: S1084-208X(10)00022-4

doi: 10.1053/j.trap.2010.03.005

Techniques in Regional Anesthesia & Pain Management
Volume 14, Issue 2 , Pages 65-74 , April 2010

Article Tools